188 related articles for article (PubMed ID: 23912487)
41. Chronic restraint stress promotes the mobilization and recruitment of myeloid-derived suppressor cells through β-adrenergic-activated CXCL5-CXCR2-Erk signaling cascades.
Cao M; Huang W; Chen Y; Li G; Liu N; Wu Y; Wang G; Li Q; Kong D; Xue T; Yang N; Liu Y
Int J Cancer; 2021 Jul; 149(2):460-472. PubMed ID: 33751565
[TBL] [Abstract][Full Text] [Related]
42. Targeting psychoemotional stress to treat prostate cancer.
Kulik G
Asian J Androl; 2013 May; 15(3):362-3. PubMed ID: 23584381
[No Abstract] [Full Text] [Related]
43. Molecular Mechanisms Underlying Psychological Stress and Cancer.
Shin KJ; Lee YJ; Yang YR; Park S; Suh PG; Follo MY; Cocco L; Ryu SH
Curr Pharm Des; 2016; 22(16):2389-402. PubMed ID: 26916018
[TBL] [Abstract][Full Text] [Related]
44. Functionality of beta-adrenergic receptors in patients with cirrhosis treated chronically with non-selective beta-blockers.
Almenara S; Lozano B; Gimenez P; Herrera I; Miralles C; Bellot P; Rodríguez M; Francés R; Gonzalez-Navajas JM; Pascual S; Zapater P
Hepatol Int; 2020 Sep; 14(5):858-868. PubMed ID: 32885366
[TBL] [Abstract][Full Text] [Related]
45. Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment.
Paran E; Neumann L; Cristal N
Eur J Clin Pharmacol; 1992; 43(1):11-5. PubMed ID: 1354617
[TBL] [Abstract][Full Text] [Related]
46. [Update on beta blockers in 2020].
Bejan-Angoulvant T; Angoulvant D
Rev Med Interne; 2020 Nov; 41(11):741-747. PubMed ID: 32532560
[TBL] [Abstract][Full Text] [Related]
47. Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts.
Flint MS; Baum A; Episcopo B; Knickelbein KZ; Liegey Dougall AJ; Chambers WH; Jenkins FJ
Stress; 2013 Jan; 16(1):114-21. PubMed ID: 22506837
[TBL] [Abstract][Full Text] [Related]
48. Trial watch: beta-blockers in cancer therapy.
Carnet Le Provost K; Kepp O; Kroemer G; Bezu L
Oncoimmunology; 2023; 12(1):2284486. PubMed ID: 38126031
[TBL] [Abstract][Full Text] [Related]
49. [Stress and pancreatic carcinoma--β-adrenergic signaling and tumor biology].
Hefner J; Csef H; Kunzmann V
Dtsch Med Wochenschr; 2014 Feb; 139(7):334-8. PubMed ID: 24496896
[TBL] [Abstract][Full Text] [Related]
50. Nasal IgA secretion in a murine model of acute stress. The possible role of catecholamines.
Jarillo-Luna RA; Rivera-Aguilar V; Pacheco-Yépez J; Godínez-Victoria M; Oros-Pantoja R; Miliar-García A; Campos-Rodríguez R
J Neuroimmunol; 2015 Jan; 278():223-31. PubMed ID: 25468772
[TBL] [Abstract][Full Text] [Related]
51. The impact of catecholamines in patients with or without beta-blockers on the ventricular fibrillation cycle length and ventricular fibrillation cycle length variability.
Min B; Kluger J; Kalus JS; Guertin D; McBride BF; White CM
Ann Noninvasive Electrocardiol; 2005 Jul; 10(3):305-11. PubMed ID: 16029381
[TBL] [Abstract][Full Text] [Related]
52. Stress-induced epinephrine levels compromise murine dermal fibroblast activity through β-adrenoceptors.
Romana-Souza B; Otranto M; Almeida TF; Porto LC; Monte-Alto-Costa A
Exp Dermatol; 2011 May; 20(5):413-9. PubMed ID: 21366703
[TBL] [Abstract][Full Text] [Related]
53. Infantile hemangioma and β-blockers: When, how, and why?
Navarro-Triviño FJ; Ruíz-Villaverde R; Naranjo-Sintes R
Actas Dermosifiliogr; 2016 Sep; 107(7):601-2. PubMed ID: 27208910
[No Abstract] [Full Text] [Related]
54. Chronic restraint stress promotes hepatocellular carcinoma growth by mobilizing splenic myeloid cells through activating β-adrenergic signaling.
Jiang W; Li Y; Li ZZ; Sun J; Li JW; Wei W; Li L; Zhang C; Huang C; Yang SY; Yang J; Kong GY; Li ZF
Brain Behav Immun; 2019 Aug; 80():825-838. PubMed ID: 31125710
[TBL] [Abstract][Full Text] [Related]
55. Prevention of skin carcinogenesis by the β-blocker carvedilol.
Chang A; Yeung S; Thakkar A; Huang KM; Liu MM; Kanassatega RS; Parsa C; Orlando R; Jackson EK; Andresen BT; Huang Y
Cancer Prev Res (Phila); 2015 Jan; 8(1):27-36. PubMed ID: 25367979
[TBL] [Abstract][Full Text] [Related]
56. Studies of catecholamine effect on cyclic AMP in human cultured thyroid cells: their interaction with thyrotrophin receptor.
Toccafondi RS; Brandi ML; Rotella CM; Zonefrati R
Acta Endocrinol (Copenh); 1983 Jan; 102(1):62-7. PubMed ID: 6130662
[TBL] [Abstract][Full Text] [Related]
57. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
Galitzky J; Reverte M; Carpene C; Lafontan M; Berlan M
J Pharmacol Exp Ther; 1993 Jul; 266(1):358-66. PubMed ID: 8101220
[TBL] [Abstract][Full Text] [Related]
58. [Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences].
Léauté-Labrèze C; Taïeb A
Ann Dermatol Venereol; 2008 Dec; 135(12):860-2. PubMed ID: 19084699
[No Abstract] [Full Text] [Related]
59. Blockade of catecholamine-induced growth by adrenergic and dopaminergic receptor antagonists in Escherichia coli O157:H7, Salmonella enterica and Yersinia enterocolitica.
Freestone PP; Haigh RD; Lyte M
BMC Microbiol; 2007 Jan; 7():8. PubMed ID: 17263883
[TBL] [Abstract][Full Text] [Related]
60. Intercepting neoplastic progression in lung malignancies via the beta adrenergic (β-AR) pathway: implications for anti-cancer drug targets.
Al-Wadei HA; Ullah MF; Al-Wadei MH
Pharmacol Res; 2012 Jul; 66(1):33-40. PubMed ID: 22487140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
